Closed-loop TBS Targeting rPO for the Core Clinical Features of Methamphetamine Use Disorder
Key facts
- Who runs it
- Shanghai Mental Health Center
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 5 people, planned
- Started
- 5 Aug 2026
- Expected to end
- Dec 2026
- Type of study
- Interventional
- Treatments tested
- Closed-loop Theta-Burst Stimulation (TBS) Targeting rPO
- Record updated
- 2 November 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Aged 18 years old or older, with at least 9 years of education (junior high school or above) or able to fully understand the task
- Meets Diagnostic and Statistical Manual of Mental Disorder, 5th Edition (DSM-5) for mild/severe amphetamine-type substance use disorder
- History of amphetamine-type substance use for no less than 1 year, with use at least once per week
Who cannot take part
- Presence of any organic disease, or diagnosis of any other psychiatric disorder according to DSM-5 (e.g., bipolar disorder, major depression disorder)
- Contraindications to TMS, as assessed by the Transcranial Magnetic Stimulation Adult Safety Screen (TASS)
- Inability to complete assessments, treatment procedures, or follow-up due to cognitive or behavioral limitations
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to evaluate whether closed-loop theta-burst stimulation (TBS) targeting the right parietal-occipital cortex (rPO) can improve core clinical symptoms in individuals with methamphetamine use disorder (MUD), such as cue-reactivity and impaired inhibitory control.
Read full original descriptionShow less
The main questions it aims to answer are:
Can closed-loop rPO-TBS significantly reduce cue-reactivity, as measured by a Visual Analog Scale (VAS) and a cue-reactivity task? Does closed-loop stimulation enhance cognitive control, assessed by performance on the Stop Signal Task (SST)?
Researchers will administer closed loop TBS to determine whether it can improve the core symptoms of MUD.
Participants will:
Complete a single closed-loop session. Receive theta-burst stimulation targeting the right parietal-occipital cortex while completing the cue-reactivity task.
Undergo cue-reactivity assessment using a Visual Analog Scale (VAS) and complete the Stop Signal Task (SST) before and after the stimulation session.
The group in the trial
- Closed-loop GroupTreatment being tested
Before stimulation: The researchers measure the participant's Resting Motor Threshold (RMT) and assess their craving using VAS before and after viewing a methamphetamine-related video. The participants complete SST. During the stimulation phase, participants will: First undergo a training phase, during which EEG will be recorded while they perform a cue-reactivity task to identify neural signatures and calculate stimulation thresholds. Then perform the cue-reactivity task again, and real-time Electroencephalography (EEG) features will be used to trigger Transcranial Magnetic Stimulation (TMS) in a closed-loop mode. After the stimulation, participants will: The researchers again assess their craving using VAS before and after viewing a methamphetamine-related video. The participants again complete the SST. The researchers record adverse reactions and adverse events, and evaluate the blinding effect, through a Blinding Assessment Questionnaire.
Treatment: Closed-loop Theta-Burst Stimulation (TBS) Targeting rPO
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Pilot Single-Arm Study of Closed-Loop Theta-Burst Stimulation (TBS) Targeting the Right Parietal-Occipital Cortex (rPO) for Core Clinical Features of Methamphetamine Use Disorder
- Record updated
- 2 November 2026